The protective effect of KCNMB1 E65K against hypertension is restricted to blood pressure treatment with beta-blockade.
Kelley-Hedgepeth
A
A
Peter
I
I
Kip
Ke
K
Montefusco
Mc
M
Kogan
S
S
Cox
D
D
Ordovas
Jm
J
Levy
D
D
Reis
Se
S
Mendelsohn
Me
M
Housman
D
D
Huggins
Gs
G
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D001794:Blood Pressure / Q000235:genetics*; D015331:Cohort Studies; D005260:Female; D005787:Gene Frequency / Q000235:genetics; D006801:Humans; D006973:Hypertension / Q000188:drug therapy* / Q000235:genetics*; D051038:Large-Conductance Calcium-Activated Potassium Channel beta Subunits / Q000235:genetics*; D008297:Male; D011110:Polymorphism, Genetic / Q000235:genetics*; D044465:White People / Q000235:genetics
D000319:Adrenergic beta-Antagonists; C531905:KCNMB1 protein, human; D051038:Large-Conductance Calcium-Activated Potassium Channel beta Subunits